No Data
Novo Nordisk Shares Rally Despite Setback in Obesity Drug Trial Results
FDA Approves First Generic of Novo Nordisk's Victoza
Novo-Nordisk A/S Options Spot-On: On December 23rd, 100.63K Contracts Were Traded, With 599.3K Open Interest
On December 23rd ET, $Novo-Nordisk A/S(NVO.US)$ had active options trading, with a total trading volume of 100.63K options for the day, of which put options accounted for 46.05% of the total
Tech Stocks Eye Christmas Gains, Microstrategy Tumbles As Bitcoin Dips To $93,000: What's Driving Markets Monday?
European Equities Traded in the US as American Depositary Receipts Start Week Down Slightly in Monday Trading
NVO Stock Plunges as Obesity Drug CagriSema Misses Target in Phase III